Title : Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.

Pub. Date : 2018 Jan

PMID : 28479237






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 S-TRAC provides evidence that 1 year of adjuvant sunitinib in patients with higher risk locoregional disease increases the median time to recurrence. Sunitinib T cell receptor alpha constant Homo sapiens